Ardelyx Reports Q1 2026 Earnings with Revenue Growth and Guidance Reiteration
Ardelyx (ARDX) reported Q1 2026 earnings with total product revenue of $93.4 million, up 38% year-over-year, driven by strong performance in Ibsrela and Exposa. The company reiterated its 2026 revenue guidance for Ibsrela and Exposa, despite a net loss of $37.6 million.
Topics: earnings financial performance guidance product revenue revenue growth